AVITA Medical, Inc. (RCEL)
NASDAQ: RCEL · Real-Time Price · USD
7.96
-0.18 (-2.21%)
Apr 1, 2025, 10:33 AM EDT - Market open
AVITA Medical Stock Forecast
Stock Price Forecast
The 4 analysts with 12-month price forecasts for AVITA Medical stock have an average target of 17.25, with a low estimate of 12 and a high estimate of 22. The average target predicts an increase of 116.71% from the current stock price of 7.96.
Analyst Consensus: Buy
Analyst Ratings
The average analyst rating for AVITA Medical stock from 5 stock analysts is "Buy". This means that analysts believe this stock is likely to outperform the market over the next twelve months.
Recommendation Trends
Rating | Oct '24 | Nov '24 | Dec '24 | Jan '25 | Feb '25 | Mar '25 |
---|---|---|---|---|---|---|
Strong Buy | 0 | 0 | 1 | 2 | 2 | 2 |
Buy | 1 | 1 | 1 | 1 | 1 | 1 |
Hold | 2 | 2 | 2 | 2 | 2 | 2 |
Sell | 0 | 0 | 0 | 0 | 0 | 0 |
Strong Sell | 0 | 0 | 0 | 0 | 0 | 0 |
Total | 3 | 3 | 4 | 5 | 5 | 5 |
Latest Forecasts
Analyst | Firm | Rating | Rating | Action | Price Target | Upside | Date |
---|---|---|---|---|---|---|---|
D. Boral Capital | D. Boral Capital | Strong Buy Maintains $22 | Strong Buy | Maintains | $22 | +176.38% | Mar 18, 2025 |
D. Boral Capital | D. Boral Capital | Strong Buy Maintains $25 → $22 | Strong Buy | Maintains | $25 → $22 | +176.38% | Feb 20, 2025 |
D. Boral Capital | D. Boral Capital | Strong Buy Maintains $25 | Strong Buy | Maintains | $25 | +214.07% | Feb 14, 2025 |
Lake Street | Lake Street | Strong Buy Maintains $20 → $14 | Strong Buy | Maintains | $20 → $14 | +75.88% | Jan 8, 2025 |
D. Boral Capital | D. Boral Capital | Strong Buy Maintains $25 | Strong Buy | Maintains | $25 | +214.07% | Jan 8, 2025 |
Financial Forecast
Revenue This Year
104.03M
from 64.25M
Increased by 61.91%
Revenue Next Year
136.65M
from 104.03M
Increased by 31.36%
EPS This Year
-0.69
from -2.39
EPS Next Year
-0.15
from -0.69
Revenue Forecast
Revenue | 2025 | 2026 | 2027 | 2028 | 2029 |
---|---|---|---|---|---|
High | 110.4M | 162.8M | 312.9M | ||
Avg | 104.0M | 136.7M | 227.0M | ||
Low | 97.9M | 121.4M | 144.3M |
Revenue Growth
Revenue Growth | 2025 | 2026 | 2027 | 2028 | 2029 |
---|---|---|---|---|---|
High | 71.7% | 56.4% | 128.9% | ||
Avg | 61.9% | 31.4% | 66.1% | ||
Low | 52.4% | 16.7% | 5.6% |
EPS Forecast
EPS | 2025 | 2026 | 2027 | 2028 | 2029 |
---|---|---|---|---|---|
High | -0.18 | 0.04 | 5.69 | ||
Avg | -0.69 | -0.15 | 2.77 | ||
Low | -0.99 | -0.31 | 0.01 |
EPS Growth
EPS Growth | 2025 | 2026 | 2027 | 2028 | 2029 |
---|---|---|---|---|---|
High | - | - | - | ||
Avg | - | - | - | ||
Low | - | - | - |
Sources: Price targets and analyst ratings provided by Benzinga. Revenue and EPS forecast data provided by Finnhub. The data is sourced from Wall Street analysts. Data disclaimer.